Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: Drug price negotiations | Trends in interventional cardiology | Doc sues health system | Valve durability & TAVR

News You Need to Know Today
Week in Review: Drug price negotiations | Trends in interventional cardiology | Doc sues health system | Valve durability & TAVR
Saturday, January 25, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 
READ MORE >

Diabetes reduces survival after SAVR, but not TAVR

"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

READ MORE >
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Share on Twitter Share on Facebook Share on Linkedin

Diabetes reduces survival after SAVR, but not TAVR

Share on Twitter Share on Facebook Share on Linkedin
A TAVR procedure being performed at Northwestern Medicine in Chicago.
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
READ MORE >

FDA regulator examines AI's growing influence in cardiology

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

READ MORE >
Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.
Share on Twitter Share on Facebook Share on Linkedin

FDA regulator examines AI's growing influence in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Stephen Browning, FDA assistant director for hemodynamic and heart failure diagnostics, explains the FDA perspectives and regulatory pathways for AI-enabled cardiovascular devices at TCT 2024.
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
READ MORE >

Medtronic heart rhythm technologies on full display at AF Symposium 2025

Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston. 

READ MORE >
Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
Share on Twitter Share on Facebook Share on Linkedin

Medtronic heart rhythm technologies on full display at AF Symposium 2025

Share on Twitter Share on Facebook Share on Linkedin
Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston. 
READ MORE >

New directions and trends in interventional cardiology

Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 

READ MORE >
George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.
Share on Twitter Share on Facebook Share on Linkedin

New directions and trends in interventional cardiology

Share on Twitter Share on Facebook Share on Linkedin
George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.
Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 
READ MORE >

PET-CT seeing increasing adoption, and now more affordable systems have facilities taking a closer look

Sponsored by Positron

The American Society of Nuclear Cardiology (ASNC) says positron emission tomography (PET) nuclear imaging has seen wider adoption in the past few years, and many cardiac imaging experts say it could become the workhorse technology for nuclear cardiac assessments over the next decade. 

READ MORE >
Neusight PET
Share on Twitter Share on Facebook Share on Linkedin

PET-CT seeing increasing adoption, and now more affordable systems have facilities taking a closer look

Sponsored by Positron

Share on Twitter Share on Facebook Share on Linkedin
Neusight PET
The American Society of Nuclear Cardiology (ASNC) says positron emission tomography (PET) nuclear imaging has seen wider adoption in the past few years, and many cardiac imaging experts say it could become the workhorse technology for nuclear cardiac assessments over the next decade. 
READ MORE >

Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment

The veteran doctor says she was treated “vastly different from her male counterparts” during her 17 years with Lehigh Valley Health Network.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The veteran doctor says she was treated “vastly different from her male counterparts” during her 17 years with Lehigh Valley Health Network.
READ MORE >

Heart surgeons may deliver better outcomes during stressful procedures

Excessive stress may still be harmful to a surgeon's performance, researchers warned, but moderate stress early on during a procedure appears to reduce the odds of a major complication. 

READ MORE >
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeons may deliver better outcomes during stressful procedures

Share on Twitter Share on Facebook Share on Linkedin
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
Excessive stress may still be harmful to a surgeon's performance, researchers warned, but moderate stress early on during a procedure appears to reduce the odds of a major complication. 
READ MORE >

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.

READ MORE >
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

Share on Twitter Share on Facebook Share on Linkedin
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
READ MORE >

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Robotic aortic valve replacement gaining momentum | Key takeaways from TCT 2025 | Repairing two valves at once
AI dramatically improves heart attack detection | FDA clears coronary plaque analysis software | Heartflow takes on PCI planning
New guidance covers ablations in ASCs | Gregg Stone on ATHENS-HF | Abbott's warning after deaths | IVC filter recalled
MPFS cuts cardiologist pay | New ablation policy a 'tremendous victory' | Medtronic's strong quarter | Medline files for IPO
CMS to cover cardiac ablations performed in ASCs | FDA clears TAVR guidewire | A new way to repair 2 heart valves at once
News Alert: CMS to cover cardiac ablations performed in ambulatory surgical centers
The first heart device of its kind | Stem cell patch impresses | FDA sees promise in new therapy | MAC linked to major risks

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …38
    • Page 39
    • Page 40
    • Page 41
    • Current page 42
    • Page 43
    • Page 44
    • Page 45
    • Page 46 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup